Cell cycle checkpoint signaling: Cell cycle arrest versus apoptosis

Toxicology

Volumn 181-182, Issue , 2002, Pages 475-481

  Pietenpol, J A ^a   Stewart, Z A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticancer therapeutics; Cancer; G1 checkpoint; G2 checkpoint; G2 override; p53

Indexed keywords

PROTEIN P53; TOXIC SUBSTANCE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL FUNCTION; ENVIRONMENTAL EXPOSURE; GENE TARGETING; GROWTH INHIBITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; CELL CYCLE; G1 PHASE; G2 PHASE; GENES, P53; HUMANS; SIGNAL TRANSDUCTION;

EID: 18144434267     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00460-2     Document Type: Article

References (43)

1. Bennett M., Macdonald K., Chan S.W., Luzio J.P., Simari R., Weissberg P. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science. 282:1998;290-293.
2. 2 arrest after DNA damage. Science. 282:1998;1497-1501.
3. Bunz F., Hwang P.M., Torrance C., Waldman T., Zhang Y., Dillehay L., Williams J., Lengauer C., Kinzler K.W., Vogelstein B. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest. 104:1999;263-269.
4. Burns T.F., El-Deiry W.S. The p53 pathway and apoptosis. J. Cell Physiol. 181:1999;231-239.
5. Caelles C., Helmberg A., Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature. 370:1994;220-223.
6. Canman C.E., Lim D.S. The role of ATM in DNA damage responses and cancer. Oncogene. 17:1998;3301-3308.
7. Chan T.A., Hermeking H., Lengauer C., Kinzler K.W., Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature. 401:1999;616-620.
8. Chao C., Saito S., Kang J., Anderson C.W., Appella E., Xu Y. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J. 19:2000;4967-4975.
9. Chehab N.H., Malikzay A., Appel M., Halazonetis T.D. Chk2/hCds1 functions as a DNA damage checkpoint in G1 by stabilizing p53. Genes Dev. 14:2000;278-288.
10. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12:1998;2245-2262.
11. Flatt P.M., Polak K., Tang L.J., Scatena C.D., Westfall M.D., Rubinstein L.A., Vogelstein B., Hill D.E., Pietenpol J.A. p53-dependent induction of PIG3 during proliferation, genotoxic stress, and reversible growth arrest. Cancer Lett. 156:2000;63-72.
12. 2 checkpoint is retinoblastoma protein dependent. Mol. Cell. Biol. 20:2000;4210-4223.
13. Friesen C., Herr I., Krammer P.H., Debatin K.M. Involvement of the CD95 (APO 1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 2:1996;574-577.
14. Furnari B., Rhind N., Russell P. Cdc25C mitotic inducer targeted by Chk1 DNA damage checkpoint kinase. Science. 277:1997;1495-1497.
15. Hartwell L.H., Weinert T.A. Checkpoints: controls that ensure the order of cell cycle events. Science. 246:1989;629-634.
16. Hirao A., Kong Y.Y., Matsuoka S., Wakeham A., Ruland J., Yoshida H., Liu D., Elledge S.J., Mak T.W. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science. 287:2000;1824-1827.
17. Hwang A., Muschell R.J. Radiation and the G2 phase of the cell cycle. Radiat. Res. 150:1998;S52-S59.
18. 2 checkpoint through cyclin B1. Proc. Natl. Acad. Sci. USA. 96:1999;2147-2152.
19. Jimenez G.S., Nister M., Stommel J.M., Beeche M., Barcarse E.A., Zhang X.Q., O'Gorman S., Wahl G.M. A transactivation-deficient mouse model provides insight into Trp53 regulation and function. Nat. Genet. 26:2000;37-43.
20. Lopez-Girona A., Furnari B., Mondesert O., Russell P. Nuclear localization of Cdc25C is regulated by DNA damage and a 14-3-3 protein. Nature. 397:1999;172-175.
21. Matsuoka S., Huang M., Elledge S.J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science. 282:1998;1893-1897.
22. Miyashita T., Harigai M., Hanada M., Reed J.C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54:1994;3131-3135.
23. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
24. Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell. 7:2001;693-694.
25. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and cadidate mediator of p53-induced apoptosis. Science. 288:2000;1053-1058.
26. Oda K., Arakawa H., Tanaka T., Matsuda K., Tanikawa C., Mori T., Nishimori H., Tamai K., Tokino T., Nakamura Y., Taya Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation of Ser-46-phosphorylatioed p53. Cell. 102:2000;849-862.
27. 2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science. 277:1997;1501-1505.
28. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A model for p53-induced apoptosis. Nature. 389:1997;300-305.
29. 2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide. Cancer Res. 58:1998;5701-5706.
30. Russell K.J., Wiens L.W., Demers W., Galloway D.A., Plon S.E., Groudine M. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1-checkpoint competent cells. Cancer Res. 55:1995;1639-1642.
31. Sanchez Y., Wong S., Thoma R.S., Richman R., Wu Z., Piwnica-Worms H., Elledge S.J. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25C. Science. 277:1997;1497-1501.
32. 1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
33. Shieh S.Y., Ahn J., Tamai K., Taya Y., Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14:2000;289-300.
34. Sionov R.V., Haupt Y. The cellular response to p53: the decision between life and death. Oncogene. 18:1999;6145-6157.
35. 1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis. Cancer Res. 59:1999;3831-3837.
36. Stewart Z.A., Pietenpol J.A. p53 signaling and cell cycle checkpoints. Chem. Res. Toxicol. 14:2001;243-263.
37. Taylor W.R., DePrimo S.E., Agarwal A., Agarwal M.L., Schönthal A.H., Katula K.S., Stark G.R. Mechanisms of G2 arrest in response to overexpression of p53. Mol. Biol. Cell. 10:1999;3607-3622.
38. Thomas A., Giesler T., White E. p53 mediates Bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway. Oncogene. 19:2000;5259-5269.
39. Wang Q., Fan S., Eastman A., Worland P.J., Sausville E.A., O'Connor P.M. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. J. Natl. Cancer Inst. 88:1996;956-965.
40. 2/M cell cycle checkpoint. Proe. Natl. Acad. Sci. USA. 96:1999;3706-3711.
41. Xiong Y. Why are there so many CDK inhibitors? Biochim. Biophys. Acta Rev. Cancer. 1288:1996;1-5.
42. cdc2 kinase. Nat. Med. 2:1996;1140-1143.
43. Yu J., Zhang L., Hwang P.M., Kinzler K.W., Vogelstein B. PUMA induces rapid apoptosis of colorectal cancer cells. Mot. Cell. 7:2001;673-682.